To determine whether circulating levels of plasma kisspeptins are dependent on the stage of ovarian cancer, Jayasena et al. (43) measured the levels of plasma kisspeptin concentration in 31 patients with ovarian carcinoma (Stages I to IV) and 31 healthy volunteers, using an in-house radioimmunoassay. The gene discussed is KISS1; the disease is ovarian carcinoma.